1. Cost–benefit analysis comparing trough, two-level AUC and Bayesian AUC dosing for vancomycin. (September 2021) Authors: Lee, Brian V.; Fong, Gary; Bolaris, Michael; Neely, Michael; Minejima, Emi; Kang, Amy; Lee, Grace; Gong, Cynthia L. Journal: Clinical microbiology and infection Issue: Volume 27:Number 9(2021) Page Start: 1346.e1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Candida parapsilosis Candidemia Resistance Patterns and Treatment Outcomes: An Opportunity for Antifungal Stewardship. (4th October 2017) Authors: Fong, Gary; Ngo, Kim; Russo, Hannah; Beyda, Nicholas Journal: Open forum infectious diseases Issue: Volume 4(2017)Supplement 1 Page Start: S86 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Assessment of antimicrobial pharmacokinetics curricula across schools and colleges of pharmacy in the United States. Issue 1 (15th October 2021) Authors: Fong, Gary; Chahine, Elias B.; Justo, Julie Ann; Narayanan, Navaneeth; Heil, Emily L.; Stover, Kayla R.; Cho, Jonathan C.; Jenkins, Zachary N.; MacDougall, Conan Journal: Journal of the American College of Clinical Pharmacy Issue: Volume 5:Issue 1(2022) Page Start: 58 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 377. High Resistance and Mortality Rates in Patients With Ventricular Assist Device (VAD)-Associated Candidemia: A Need for Alternative Antifungal Strategies. (26th November 2018) Authors: Fong, Gary; Beyda, Nicholas D Journal: Open forum infectious diseases Issue: Volume 5(2018)Supplement 1 Page Start: S146 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 382. Virulence in Candida glabrata Is Not Attenuated by FKS Mutations but Associated With the Frequency of Cells With Distinct Morphology. (26th November 2018) Authors: Hu, Chenlin; Fong, Gary; Beyda, Nicholas D Journal: Open forum infectious diseases Issue: Volume 5(2018)Supplement 1 Page Start: S148 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 'Cost–benefit analysis comparing trough, two-level AUC, and Bayesian AUC dosing for vancomycin': authors' reply. (June 2021) Authors: Lee, Brian V.; Fong, Gary; Bolaris, Michael; Neely, Michael; Minejima, Emi; Kang, Amy; Lee, Grace; Gong, Cynthia L. Journal: Clinical microbiology and infection Issue: Volume 27:Number 6(2021) Page Start: 929 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Significant Publications on Infectious Diseases Pharmacotherapy in 2016. (October 2018) Authors: Fong, Gary; Skoglund, Erik W.; Phe, Kady; Guastadisegni, Jessica; Shea, Katherine M.; McDaneld, Patrick M.; Perez, Katherine K.; Sofjan, Amelia K. Journal: Journal of pharmacy practice Issue: Volume 31:Number 5(2018:Oct.) Page Start: 469 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Before-After Study of an Electronic Order Set for Reversal of Vitamin K Antagonist–Associated Intracerebral Hemorrhage. (January 2018) Authors: Vitt, Jeffrey R.; Do, Lynn V.; Shah, Nirav H.; Fong, Gary; Nguyen, Nicole Y.; Kim, Anthony S. Journal: Neurohospitalist Issue: Volume 8:Number 1(2018) Page Start: 18 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗